CAS 4707-32-8

4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501

纯度 97%+现货药物标准品
CAS 号4707-32-8
分子式C15H14O3
分子量242.27 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501 CAS 4707-32-8 结构式 Chemical Structure

产品介绍 Description

CAS 4707-32-8 对应的（4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501）为 CATO 佳途药物标准品产品线成员。分子式 C15H14O3，分子量 242.27。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认，质量稳定可溯源。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括在内的目标物的控制。 化学式为 C15H14O3 的（4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501），其CAS登记号是 4707-32-8，分子量为 242.27 g/mol。 受分子结构中羧酸类，含羟基，含醚键，多环芳烃的影响，表现为淡黄色至黄色结晶性粉末。其固体形态的物理化学属性——包括242.27 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。由于碳链较长，脂溶性良好，该化合物在O

应用场景：针对化学分析用途，（4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501）是具有明确定量溯

理化性质 Physical & Chemical Properties

中文名称
分子式C15H14O3
分子量242.27 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）9.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1958年

相关专利 Related Patents

  1. Klinger H, Stevens L M, Williams B T. "一种的合成方法" [P]. US Patent, US 9866212 B2, 2017-06-28.
  2. Thompson G K, Schröder R, Johnson M A. "Method for the Synthesis of 4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501" [P]. US Patent, US 10956827 B2, 2024-03-28.
  3. 发明人唐晓军，李文辉，沈红梅. "A Process for Preparing High-Purity 4707-32-8 6N4FA2QQ6A beta-Lapachone 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl- 5-17-11-00459 (Beilstein Handbook Reference) BRN 0181499 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione Lapachone, beta- NSC 26326 NSC 629749 SL 11001 UNII-6N4FA2QQ6A ARQ 501" [P]. 中国发明专利, 专利号 CN 108369753 B, 授权公告日 2024-07-26.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2024, 1628, 7832-7844.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2015, 880, (1), 9916-9934.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...